- Home
- TYGO vs RENB Comparison
TYGO vs RENB Comparison
Compare TYGO & RENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TYGO
- RENB
- Stock Information
- Founded
- TYGO 2007
- RENB 2011
- Country
- TYGO United States
- RENB United States
- Employees
- TYGO N/A
- RENB N/A
- Industry
- TYGO Semiconductors
- RENB Biotechnology: Pharmaceutical Preparations
- Sector
- TYGO Technology
- RENB Health Care
- Exchange
- TYGO Nasdaq
- RENB Nasdaq
- Market Cap
- TYGO 51.5M
- RENB 61.0M
- IPO Year
- TYGO N/A
- RENB N/A
- Fundamental
- Price
- TYGO $0.90
- RENB $0.32
- Analyst Decision
- TYGO Buy
- RENB
- Analyst Count
- TYGO 3
- RENB 0
- Target Price
- TYGO $3.00
- RENB N/A
- AVG Volume (30 Days)
- TYGO 20.5K
- RENB 692.5K
- Earning Date
- TYGO 05-06-2025
- RENB 05-19-2025
- Dividend Yield
- TYGO N/A
- RENB N/A
- EPS Growth
- TYGO N/A
- RENB N/A
- EPS
- TYGO N/A
- RENB N/A
- Revenue
- TYGO $63,051,000.00
- RENB N/A
- Revenue This Year
- TYGO $61.65
- RENB N/A
- Revenue Next Year
- TYGO $28.03
- RENB N/A
- P/E Ratio
- TYGO N/A
- RENB N/A
- Revenue Growth
- TYGO N/A
- RENB N/A
- 52 Week Low
- TYGO $0.58
- RENB $0.29
- 52 Week High
- TYGO $1.85
- RENB $2.34
- Technical
- Relative Strength Index (RSI)
- TYGO 57.62
- RENB 37.38
- Support Level
- TYGO $0.81
- RENB $0.29
- Resistance Level
- TYGO $0.93
- RENB $0.35
- Average True Range (ATR)
- TYGO 0.06
- RENB 0.05
- MACD
- TYGO 0.01
- RENB 0.01
- Stochastic Oscillator
- TYGO 83.70
- RENB 18.83
About TYGO Tigo Energy Inc.
Tigo Energy Inc designs solar power conversion and storage products that provide customers with more choice and flexibility. Its mission is to deliver smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems. Geographically the company generates revenue from EMEA, Americas, and APAC.
About RENB Renovaro Biosciences Inc.
Renovaro Inc is a biopharmaceutical company. It is engaged in developing new immunotherapies to combat cancer and developing a predicative artificial intelligence-based diagnostic methodology for the use of earlier cancer detection.